Quality control measures for drug development are of utmost importance as inadvertent presence of unknown pharmaceutical ingredients can further complicate health conditions of the patients. Government authorities are closely watching over pharmaceutical companies and regulating their drug manufacturing processes by compelling them to undertake safety tests. Large and complex molecules such as biologics, which are produced from genes of living organisms through advanced DNA technologies, are ... Read more
Global Biologics Safety Testing Market Report: By Product (Kits & Reagents, Instruments, Services), Test (Sterility, Endotoxin, Cell Line Authentication), Application (Vaccine Development, Blood Products, Stem Cell Research)—Global Forecast till 2023
Market Scenario:
The global biologics safety testing market is expected to grow significantly over the forecast period. The market held a market value of USD 2.79 billion in 2017 and is projected to register ... Read more
The global biologics safety testing market is foreseen to increase growth on the back of the rising number of drug launches and research and development investment in the life sciences industry. Government support for the biotechnology and pharmaceutical industries could also help the market to increase growth in the near future. Among key products offered in the market, kits and reagents are foretold to become largely ... Read more
Quality control measures for drug development are of utmost importance as inadvertent presence of unknown pharmaceutical ingredients can further complicate health conditions of the patients. Government authorities are closely watching over pharmaceutical companies and regulating their drug manufacturing processes by compelling them to undertake safety tests. Large and complex molecules such as biologics, which are produced from genes of living organisms through advanced DNA technologies, are ... Read more
The global biologics safety testing market is foreseen to increase growth on the back of the rising number of drug launches and research and development investment in the life sciences industry. Government support for the biotechnology and pharmaceutical industries could also help the market to increase growth in the near future. Among key products offered in the market, kits and reagents are foretold to become largely ... Read more
According to research report the global Biologics Safety Testing Market is expected to reach USD 4.90 Billion by 2022 from USD 2.75 Billion in 2017, at a CAGR of 12.2% from 2017 to 2022.
Growth in pharmaceutical and biotechnology industry driven by government support in both industries, the positive trend of R&D investment in the life sciences industry and ... Read more
The Global Biologics Safety Testing held a Market value of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants.
Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. However, stringent government regulations ... Read more
Market Research Future (MRFR) in their latest report of the biologics safety testing market revealed that the market can achieve 13.6% CAGR during the forecast period (2018-2023). The biologics safety testing market can scale far better Biologics Safety Testing Market Sharevaluation than its previous USD 2.79 ... Read more
